Recruiting Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression NCT04363164 Conditions Castration Resistant Metastatic Prostate Cancer Locations University of California, San Diego (UCSD) — San Diego, California, United States Johns Hopkins University/Sidney Kimmel Cancer Center — Baltimore, Maryland, United States Dana-Faber Cancer Institute — Boston, Massachusetts, United States University of Minnesota — Minneapolis, Minnesota, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer NCT07581184 Conditions B7H3, Castration Resistant Metastatic Prostate Cancer, Genital Diseases, +12 more Locations Hoag Memorial Hospital Presbyterian — Irvine, California, United States Biogenix Molecular, LLC — Miami, Florida, United States BAMF Health — Grand Rapids, Michigan, United States XCancer — Omaha, Nebraska, United States View Trial Details
Recruiting The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC) NCT07038304 Conditions Adenocarcinoma, Carcinoma, Castration Resistant Metastatic Prostate Cancer, +15 more Locations UMC Groningen — Groningen, Netherlands Radboud Umc — Nijmegen, Netherlands View Trial Details
Completed Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance NCT02286921 Conditions Castration Resistant Metastatic Prostate Cancer Locations Unversity of Alabama — Birmingham, Alabama, United States City of Hope — Duarte, California, United States University of Colorado Cancer Center — Aurora, Colorado, United States Sibley Memorial Hospital — Washington D.C., District of Columbia, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
